ALLVIL 2ML INJ
— Product

ALLVIL 2ML INJ

PHENIRAMINE MELEATE 22.75MG 2ML INJ

ALLVIL 2ML INJ is an injection of pheniramine maleate 22.75 mg in 2 ml, a first-generation antihistamine given intramuscularly or by slow intravenous injection. It is used for acute allergic reactions — urticaria, angioedema, drug and insect-sting reactions, and allergic rhinitis where an oral dose is impractical — and as an adjunct in anaphylaxis after adrenaline has been given.

01

Benefits

  • The injectable route gives rapid onset where an allergic reaction is severe or the patient cannot take oral medication.
  • Blocks histamine H1 receptors, relieving the itching, weals and flushing of acute allergic reactions.
  • Useful adjunct in anaphylaxis alongside adrenaline and corticosteroid, though never as a substitute for adrenaline.
  • Widely used as pre-medication before transfusion or before agents with a known risk of hypersensitivity reaction.
  • The sedating effect can be useful where itching is severe and disturbing sleep.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Marked drowsiness and sedation
  • Dry mouth, nose and throat
  • Dizziness or unsteadiness
  • Pain or stinging at the injection site
Less common
  • Blurred vision
  • Difficulty passing urine
  • Fall in blood pressure, particularly after rapid intravenous injection
  • Palpitations, or paradoxical restlessness and excitation
Stop and get medical help if any of these occur
  • Severe drowsiness progressing to unresponsiveness
  • Marked fall in blood pressure or fainting
  • Seizures
  • Difficulty breathing, or worsening of the reaction being treated
  • Inability to pass urine
03

Precautions

  • For administration by a qualified healthcare professional only. Intravenous doses must be given slowly and with the patient monitored.
  • Causes marked sedation. The patient must not drive or operate machinery for the rest of the day.
  • Contraindicated in narrow-angle glaucoma, urinary retention, significant prostatic enlargement and pyloroduodenal obstruction.
  • Contraindicated in neonates and premature infants, and not to be given with, or within fourteen days of, a monoamine oxidase inhibitor.
  • Sedation is additive with alcohol, opioids, benzodiazepines and other central depressants — avoid the combination or reduce doses.
  • Use with care in the elderly, in epilepsy, in asthma and in hepatic impairment.
  • In anaphylaxis this is an adjunct only; adrenaline remains the first-line treatment.
  • Use in pregnancy and breastfeeding only where clearly indicated.